SCHEMBL22450955

SCHEMBL22450955

C=C(CC1CCCCC1)N1CCCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CHRM5 P08912 1/20 0.41
▸ ADRA2C P18825 1/20 0.41
▸ HPGD P15428 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ EPHX1 P07099 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ MGLL Q99685 2/20 0.33
▸ EPHX2 P34913 1/20 0.33
▸ PHGDH O43175 1/20 0.33
▸ ALDH2 P05091 1/20 0.33
▸ FBP1 P09467 1/20 0.33
▸ AR P10275 1/20 0.33
▸ TNKS2 Q9H2K2 1/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20386556 0.83 ALDH1A1 (0.38) SMN1; SMN2CHRM5ADRA2CALDH1A1KDM4E
SCHEMBL3700457 0.74 KDM4E (0.51) SMN1; SMN2HPGDKMT2AEPHX1HTT
SCHEMBL3706069 0.74 KDM4E (0.51) SMN1; SMN2HPGDKMT2AEPHX1HTT
SCHEMBL12398 0.74 KDM4E (0.51) SMN1; SMN2HPGDKMT2AEPHX1HTT
SCHEMBL12102997 0.72 KMT2A (0.40) SMN1; SMN2CHRM5ADRA2CHPGDKMT2A
SCHEMBL3704195 0.71 NAMPT (0.50) SMN1; SMN2KMT2AALDH1A1KDM4EHSD17B10
SCHEMBL3698852 0.70 ALDH1A1 (0.51) SMN1; SMN2HPGDKMT2AEPHX1ALDH1A1
SCHEMBL3707477 0.70 NAMPT (0.49) SMN1; SMN2HPGDKMT2AALDH1A1KDM4E
SCHEMBL12676065 0.69 — —
SCHEMBL7131442 0.69 HPGD (0.41) CHRM5ADRA2CHPGDKMT2AEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230432-A1 DR5 AGONIST AND IAP ANTAGONIST COMBINATION THERAPY Inhibrx, Inc. (US) 2023-11-30 — — WO disclosed
EP-3936126-A1 COMBINATION OF IAP INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2022-01-12 — — EP disclosed
EP-3712162-A1 SMAC MIMETICS USED AS IAP INHIBITORS AND USE THEREOF Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2020-09-23 — — EP disclosed
Send feedback